Verve Therapeutics, Inc. short interest in 2022
In 2022, Verve Therapeutics, Inc.'s disclosed short interest ran from 12.86% of shares outstanding on 14 Jan 2022 to 20.24% on 30 Dec 2022, a change of +7.38 percentage points. The year's high was 20.46% on 15 Jun 2022 and its low 12.86% on 14 Jan 2022, averaging 17.56% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.56 days on 15 Jun 2022. Full history: Verve Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 12.86% (14 Jan 2022)
- End of year
- 20.24% (30 Dec 2022)
- Change
- +7.38 pp
- High
- 20.46% (15 Jun 2022)
- Low
- 12.86% (14 Jan 2022)
- Average
- 17.56%
- Highest days to cover
- 16.56 (15 Jun 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 12.86% | 12.91 | |
| 31 Jan 2022 | 14.30% | 7.76 | |
| 15 Feb 2022 | 15.81% | 15.26 | |
| 28 Feb 2022 | 15.97% | 12.90 | |
| 15 Mar 2022 | 16.70% | 13.10 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 17.98% | 8.41 | |
| 14 Apr 2022 | 17.36% | 14.02 | |
| 29 Apr 2022 | 18.53% | 15.89 | |
| 13 May 2022 | 19.35% | 12.47 | 10-Q filed, results (8-K) |
| 31 May 2022 | 19.78% | 16.38 | |
| 15 Jun 2022 | 20.46% | 16.56 | |
| 30 Jun 2022 | 19.33% | 8.72 | |
| 15 Jul 2022 | 20.43% | 10.81 | |
| 29 Jul 2022 | 18.38% | 4.23 | |
| 15 Aug 2022 | 16.00% | 9.90 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 16.13% | 10.37 | |
| 15 Sep 2022 | 16.44% | 11.52 | |
| 30 Sep 2022 | 20.23% | 7.92 | |
| 14 Oct 2022 | 17.90% | 16.39 | |
| 31 Oct 2022 | 16.77% | 13.80 | |
| 15 Nov 2022 | 16.20% | 6.40 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 16.42% | 16.13 | |
| 15 Dec 2022 | 17.79% | 9.31 | |
| 30 Dec 2022 | 20.24% | 12.19 |
See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.